Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03838003
Other study ID # ERIC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date September 30, 2019

Study information

Verified date September 2017
Source Universidade do Porto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An aerobic physical exercise protocol will be applied to patients admitted in ward due to decompensated heart failure, in order to validate the efficacy and safety of physical exercise in this phase of clinical stabilization, through the said training protocol - ERIC program.


Description:

With the objective of validating the efficacy and safety of physical exercise as a therapeutic resource in patients admitted for decompensated heart failure; will be applied, by rehabilitation nurses, a protocol of physical exercise, with increasing levels of intensity. Patients who meet the inclusion criteria will be randomized through an online program (randomizer.org) and the ERIC protocol will be applied to the test group. The control group will be implemented the usual care of rehabilitation nursing. The ERIC protocol comprises 5 levels of intensity, as following shown: Stage 1 - respiratory and calisthenic exercises (5-10 minutes) Stage 2 - pedal for 5-10 minutes Stage 3 - aerobic training: walking on the corridor for 5-10 minutes Stage 4 - aerobic training: walking on the corridor for 10-15 minutes Stage 5 - aerobic training: walking on the corridor for 15 minutes + climbing stairs for 5 minutes All patients will be monitored and followed up by a rehabilitation nurse while they are doing the exercise. The investigator decides, depending on the patient's performance and clinical conditions, the form of progression in the program, but it is mandatory to follow the previously defined levels of intensity. Patients in the test group may start the program only on stage I or II according to clinical criteria. At admission of the patients (test group and control group) clinical and sociodemographic parameters are evaluated, as well as data related to Barthel's indices and London Chest of activities of daily living (LCADL). At the discharge date, the Barthel index and the LCADL scale will also be evaluated, as well as the 6-minute walking test.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date September 30, 2019
Est. primary completion date March 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Admission diagnosis of Decompensated heart failure - More than 18 years old - Capacity to provide informed consent Exclusion Criteria: - Osteoarticular pathology that impedes the performance of the exercise - Existence of inotropic infusions - Dysrhythmia or precordial pain in the last 24 hours - Acute pulmonary edema in the last 12 hours - Systolic blood pressure greater than 180millimetre of mercury (mmHg) or less than 80mmHg (except in cases where this is the baseline value for the patient) - Need for oxygen at a rate greater than 3 /min - Glycemic decompensation in the last 12 hours

Study Design


Intervention

Procedure:
ERIC protocol
ERIC protocol is an aerobic exercise protocol with 5 levels of intensity

Locations

Country Name City State
Portugal Centro Hospitalar do Porto Oporto

Sponsors (3)

Lead Sponsor Collaborator
Universidade do Porto Centro Hospitalar do Porto, Instituto Politécnico de Bragança

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary 6 minute walking test Number of meters walked in the 6 minute walking test through study completion, an average of 1 year
Secondary Barthel Index score Barthel evaluates dependence on self-care through study completion, an average of 1 year
Secondary London Chest Activity of Daily Living (LCADL) scale score LIDL accesses how dyspnea affects self-care through study completion, an average of 1 year
Secondary Number of dysrhythmias during exercise in the training group To quantify the number of dysrhythmias during exercise in the training group through study completion, an average of 1 year
Secondary Number of falls during exercise in the training group To quantify the number of falls during exercise in the training group through study completion, an average of 1 year
Secondary Number of emergency situations during exercise in the training group To quantify the number of emergency situations during exercise in the training group through study completion, an average of 1 year
Secondary Number of chest pain situations during exercise in the training group To quantify the chest pain situations during exercise in the training group through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05910437 - Optimizing Treatments for Heart Failure During Hospitalization
Terminated NCT00355017 - BNP Guided Care in Addition to Multidisciplinary Care N/A
Active, not recruiting NCT03701880 - Early Use of Ivabradine in Heart Failure N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT06114498 - Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Recruiting NCT02997462 - Monocyte Phenotypic Changes in Heart Failure
Completed NCT04493346 - Shear Wave Elastography
Recruiting NCT02666651 - Regional Tolvaptan Registry Phase 4
Recruiting NCT02236247 - Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure Phase 1/Phase 2
Not yet recruiting NCT06273397 - Acetazolamide or Metolazone in Acute Heart Failure N/A
Recruiting NCT06286423 - Colchicine in Acutely Decompensated HFREF Phase 4
Completed NCT05927285 - Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1 N/A
Withdrawn NCT04572867 - Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure N/A
Completed NCT02157506 - A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure Phase 2
Recruiting NCT03914222 - Comparing PA Compliance During and After Decompensation in HFP N/A
Recruiting NCT03009552 - Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure N/A
Completed NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) N/A
Recruiting NCT02649517 - Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction N/A
Recruiting NCT03440970 - Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure Early Phase 1
Recruiting NCT05090930 - Innovative Technologies for the Treatment of Pulmonary and Heart Failure N/A